Glenmark Life Sciences IPO To Open On July 27. Here's All You Need To Know

Glenmark Life Sciences' initial public offering (IPO) will open on July 27, 2021, Glenmark Pharma said in a regulatory filing to the stock exchanges. Glenmark Life Sciences is the API (active pharmaceutical ingredients) arm of Glenmark Pharmaceuticals. The public offering will close on July 29 and the shares are likely to be listed on the bourses on August 6.